Polycythemia Vera clinical trials at UCSF
2 in progress, 1 open to eligible people
DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
open to eligible people ages 18 years and up
This phase 1b/2a open-label study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of DISC-0974 as well as categorize the effects on hematologic response in participants with myelofibrosis or myelodysplastic syndrome and anemia.
San Francisco, California and other locations
Rusfertide in Patients With Polycythemia Vera
Sorry, in progress, not accepting new patients
The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.
San Francisco, California and other locations
Our lead scientists for Polycythemia Vera research studies include Jerry Lee, MD, MS.
Last updated: